TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
TG Therapeutics Executive Salaries
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
The average TG Therapeutics executive compensation is $268,846 a year.The median estimated compensation for executives at TG Therapeutics including base salary and bonus is $251,020, or $120 per hour. At TG Therapeutics, the most compensated executive makes $720,000, annually, and the lowest compensated makes $52,000.
Last updated months ago.
$110k
$180k
$251k
$348k
$563k
$650k
$720k
$268,846*
Average Compensation
$251,020*
Median Compensation
* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.
Executive Salaries at Similarly Sized companies in Burlington, NC
×